Brief: Sol-Gel Technologies Provides Update On FDA Review Of Epsolay

SOL-GEL TECHNOLOGIES

27/04/2021 15:39

April 27 (Reuters) - Sol Gel Technologies Ltd  SLGL.O :
    * SOL-GEL TECHNOLOGIES PROVIDES UPDATE ON FDA REVIEW OF
EPSOLAY®
    * SOL GEL TECHNOLOGIES LTD - HAS RECEIVED NO NOTIFICATION
FROM FDA
FOR REVIEW OF EPSOLAY
    * SOL GEL TECHNOLOGIES LTD - CONTINUES TO FOLLOW-UP WITH FDA
ON
SCHEDULING OF INSPECTION OF PRODUCTION SITE OF EPSOLAY
    * SOL GEL TECHNOLOGIES LTD - RECEIVED EMAIL CONFIRMATION
FROM FDA
THAT ACTION ON NDA FOR EPSOLAY COULD NOT BE TAKEN
    * SOL GEL TECHNOLOGIES LTD - RECEIVED EMAIL CONFIRMATION
FROM FDA
THAT PRE-APPROVAL INSPECTION OF PRODUCTION SITE OF EPSOLAY STILL
NEEDS TO BE CONDUCTED

Source text for Eikon:  ID:nGNX3KKtmb 
Further company coverage:  SLGL.O 

 ((Reuters.Briefs@thomsonreuters.com;))